TrialNeuropsychopharmacology reports2021

Efficacy and safety of guanfacine extended-release in Japanese adults with attention-deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study.

Noriyuki Naya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.